Haemonetics | HAE - Current Liabilities


Haemonetics reported $539.87M in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
Avanos Medical USD 147.9M 13.3M Sep/2025
Baxter International USD 2.97B 805M Dec/2025
Becton, Dickinson and Co. USD 8.76B 448M Dec/2025
Boston Scientific USD 5.44B 111M Dec/2025
Cerus USD 88.43M 4.08M Sep/2025
Cooper Companies USD 1.11B 102.7M Sep/2025
Fresenius EUR 9.56B 1.27B Sep/2025
Fresenius Medical Care EUR 5.76B 98.85M Sep/2025
Globus Medical USD 465.96M 41.29M Sep/2025
Haemonetics USD 539.87M 8.45M Dec/2025
Hologic USD 951.3M 25.9M Dec/2025
ICU Medical USD 498.86M 5.96M Dec/2025
Intuitive Surgical USD 2.52B 207.3M Dec/2025
Masimo USD 369.7M 222.4M Sep/2025
Medtronic USD 9.94B 1.6B Sep/2025
Merit Medical Systems USD 230.48M 4.9M Sep/2025
Neogen USD 147.05M 850K Sep/2025
OraSure Technologies USD 40.25M 2.1M Sep/2025
Plus Therapeutics USD 10.73M 189K Dec/2023
Quidel USD 966.1M 198.2M Dec/2025
ResMed USD 1.25B 7.39M Dec/2025
STAAR Surgical USD 61.64M 2.41M Sep/2025
Steris USD 922.3M 33.4M Dec/2025
Stryker USD 7.79B 380M Dec/2025
Surmodics USD 20.54M 347K Sep/2024
Teleflex USD 773.03M 56.88M Sep/2025
Terumo JPY 539.7B 243.4B Dec/2025
Thermo Fisher Scientific USD 15.19B 301M Dec/2025
US Physical Therapy USD 115.08M 3.76M Sep/2025
Zimmer Biomet Holdings USD 2.58B 180.8M Dec/2025